Showing 241 - 260 results of 3,993 for search '(( a ((teer decrease) OR (linear decrease)) ) OR ((( i large decrease ) OR ( a large decrease ))))', query time: 0.75s Refine Results
  1. 241

    Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …”
  2. 242
  3. 243
  4. 244
  5. 245

    Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

    Published 2024
    “…<div><p>Background</p><p>Chikungunya virus (CHIKV) outbreaks, driven by the expanding habitat of the <i>Aedes albopictus</i> mosquito and global climate change, pose a significant threat to public health. …”
  6. 246

    Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

    Published 2024
    “…<div><p>Background</p><p>Chikungunya virus (CHIKV) outbreaks, driven by the expanding habitat of the <i>Aedes albopictus</i> mosquito and global climate change, pose a significant threat to public health. …”
  7. 247
  8. 248
  9. 249
  10. 250
  11. 251
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256
  17. 257
  18. 258

    Table 1_Inflammatory parameters mediates the relationship between dietary index for gut microbiota and frailty in middle-aged and older adults in the United States: findings from a... by Qijiang Yang (21096683)

    Published 2025
    “…RCS showed that the risk of frailty decreased linearly with increasing DI-GM levels. Mediation analysis indicated significant effects for leukocyte count, neutrophil count, NLR, and SIRI, with mediation proportions of 5.7, 7.9, 4.4, and 5.5%, respectively (all p < 0.001).…”
  19. 259

    S1 Data - by Domingos L. S. Rios (20496173)

    Published 2025
    “…However, large studies providing a comprehensive longitudinal observation of patients undergoing this therapy are lacking. …”
  20. 260

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…A 365-fold improvement in potency was observed for the <i>cis</i>-2-methylcyclohexanamine analogue compared to the unsubstituted cyclohexanamine derivative. …”